For each of these 4 psychobiological disorders, OptoPath scientists have developed:
- Innovative rodent behavioral models
- Cutting edge tools for neurobiological investigations coupling technologies such as multi-sites electrophysiology, optogenetics and deep brain vascular imaging in behaving rodents.
Combining these innovative animal models and cutting-edge technologies, OptoPath provides:
- A large range of in vivo assays to evaluate the safety/therapeutic effects of novel drugs in the context of these major psychopathologies.
- Equipment marketing through its industrial partner Imetronic